OMIQ Research
Sant Cugat del Vallès, Barcelona, 08195, Spain
Location status: Recruiting
Location contact
Anna Romero, Administration
CONTACT
Mercè Guarro, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07165197
This is study to determine the visual performance of patients with age-related cataracts implanted in both eyes with either of two extended depth of focus intraocular lenses, the Clareon Vivity (Alcon Healthcare) or the PureSee (Johnson & Johnson)
Interested in participating?
Request Info50 year and older
All sexes
Interventional
Not applicable
Sant Cugat del Vallès, Barcelona, 08195, Spain
Location status: Recruiting
Anna Romero, Administration
CONTACT
Mercè Guarro, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Comparison of two different Extended depth of focus intraocular lenses
Time frame: 3 months
Time frame: 3 months
Visual acuities in logMAR scale using ETDRS (Early Treatment Diabetic Retinopathy Study) charts
Time frame: Three months
Contrast sensitivity using M&S device
Time frame: 3 months
Contrast sensitivity in logMAR scale using low contrast ETDRS (Early Treatment Diabetic Retinopathy Study) charts
Time frame: 3 months
Assessment of qualitative visual dysphotopsia using a specific validated questionnaire
Time frame: 3 months
Assessment of recent use of spectacles to see at different distances using a specific questionnaire
OMIQ Research
Network
Visual Performance of Clareon® Vivity® and PureSee® Intraocular Lenses in Patients Undergoing Cataract Surgery
Acronym: PURVI2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07468409
Cataract, Eye Diseases
Makati City, National Capital Region, Philippines
View Trial DetailsNCT07610226
Cataract, Eye Diseases
Greensboro, North Carolina, United States
View Trial DetailsNCT07715591
Anxiety Disorders, Behavior
Los Angeles, California, United States
View Trial DetailsNCT07471295
Cataract, Eye Diseases
Prague, Czechia
View Trial Details